Written and maintained by CASRAI Editorial Board
Published · Last updated
This page describes products and general use; it is not medical advice.
On this page
A highly absorbent wound dressing is a dressing built to take up and hold a large volume of wound fluid (exudate), usually with a core of superabsorbent polymer or a gelling fibre. Clinic staff, buyers and students searching this phrase usually need to know what the term covers, what these dressings are made of, and how the FDA actually records them. “Highly absorbent”, “high absorbent”, “absorbent” and “super absorbent” wound dressing are used interchangeably in product naming; none is a regulatory category.
What a highly absorbent wound dressing is
It is a sterile, single-use dressing intended for wounds that produce a lot of exudate. In its 510(k) summary for the Sorbact Superabsorbent dressing (K153674, decision 1 July 2016), the manufacturer describes the product as indicated for “heavily exuding” partial to full thickness wounds, while a sibling foam dressing in the same submission is indicated for “moderately exuding” wounds. The stated purpose is to rapidly absorb and lock exudate within an absorbent core while letting water vapour evaporate from the skin, “protecting the skin from maceration”.
Who uses it: the same 510(k) summary lists chronic wounds (venous, arterial, diabetic and pressure ulcers), postoperative dehisced wounds and traumatic wounds as the wound types for the prescription superabsorbent dressing, so wound-care clinicians and community nursing teams are the typical users.
How it is built
The K153674 summary gives a layer-by-layer description: a wound contact layer, then absorbent polyurethane foam or a superabsorbent core, covered by a semi-permeable polyurethane film or polypropylene non-woven, with a fixation border made of silicone adhesive. In its comparison table the summary names the exudate absorption material as polyurethane foam or polyacrylate superabsorbent particles. Its predicate (K143151, Cutimed Sorbact) is listed with a hydropolymer matrix or superabsorbent polyurethane foam.
Types and variants
“Super absorbent” is used for more than one material. The table below uses only products described in two FDA 510(k) summaries (K153674 and K070175); it is a set of examples, not a full market list.
| Type (example) | Absorbing material | Stated use in the summary | Source |
|---|---|---|---|
| Superabsorbent-core bordered dressing (Sorbact Superabsorbent) | Polyacrylate superabsorbent particles; contact layer, film or non-woven cover, silicone border | Heavily exuding partial to full thickness wounds; prescription use | K153674 |
| Absorbent foam bordered dressing (Sorbact Foam Gentle Border) | Polyurethane foam | Moderately exuding partial to full thickness wounds; prescription use | K153674 |
| Chitosan-based gelling dressing (AQUANOVA Super-Absorbent) | Chitosan and chitosan derivatives in a soft padded woven dressing; gels with fluid | Over-the-counter indication: minor burns, superficial cuts, lacerations and abrasions, and minor skin irritations. A separate prescription indication, under healthcare-professional supervision, covers ulcers, surgical wounds, burns and bleeding-prone wounds | K070175 |
| Hydrofibre gelling dressing (Aquacel, the comparison device) | Sodium carboxymethylcellulose; gels in the presence of fluid | Named as a comparison device; see our Aquacel guide | K070175 (comparison) |
Other products on this site that handle heavy fluid by different designs are covered in our guides to the ABD pad, calcium alginate dressings and gauze.
How the FDA records these dressings
Here is what most product pages leave out. “Superabsorbent” is a descriptive name, not an FDA classification. The openFDA classification records (checked 1 November 2026) place the two examples under different product codes: K153674 under FRO (“Dressing, Wound, Drug”, device class U, unclassified) and K070175 under QSY (“Hemostatic Wound Dressing Without Thrombin Or Other Biologics”, class U). K153674 is prescription-only, while the K070175 submission carries two Indications for Use pages: an over-the-counter one limited to minor injuries, and a prescription one for supervised use on ulcers, surgical wounds, burns and bleeding-prone wounds. So the label on the pack, not the word “absorbent”, defines the intended wound type and who may use it.
Dry wound dressing and other variants of the term
Is a highly absorbent dressing the same as a dry dressing? No. Absorbency describes how much fluid a dressing takes up. “Dry wound dressing” is a loose phrase, not a regulatory category, and it does not name a material or a product type. For how this site sorts dressings by design, see the wound care supply selection guide.
Handling and labelling basics
- The indication and instructions for use are printed on the packaging: the Sorbact examples are single-use, sterile (ethylene oxide) products, and the AQUANOVA summary describes sterile single-use pouches.
- The K153674 summary separates “moderately” from “heavily” exuding wounds between two products, so the exudate level in the indication is part of how each product is labelled.
- Prescription-only indications (as in K153674) are labelled for use under a clinician, not for self-selection from the shelf.
What the clinical evidence shows
A December 2024 in-service evaluation in the Journal of Community Nursing studied a superabsorbent polymer dressing on 12 patients for two weeks at an outpatient vascular clinic in England (venous leg ulcers, postoperative wounds, diabetic foot ulcers and lymphoedema ulcers). The abstract reports that 8 of 12 patients needed three or fewer dressing changes, that patients with maceration fell from 7 at baseline to 2, and that exudate was managed “well” or “very well” in all cases. This is a small, short evaluation of one product with no comparison group, so it describes how that dressing performed in that clinic, not how superabsorbent dressings compare with other types.
Common mistakes
- Treating “super absorbent” as one material: the examples above use polyacrylate particles, chitosan and carboxymethylcellulose.
- Assuming an OTC indication is cleared for the same wounds as a prescription one; the AQUANOVA over-the-counter indication is limited to minor burns, cuts, abrasions and skin irritations, and its wider wound types sit under a separate supervised prescription indication.
FAQ
What is the difference between absorbent, high absorbent and super absorbent wound dressings?
The words are product-naming terms, not FDA classes. In the two FDA records used for this page, “superabsorbent” appears for a polyacrylate-particle core and for a chitosan gelling pad, and the indications are tied to exudate level (moderate versus heavy) rather than to the adjective.
Is a highly absorbent wound dressing prescription or over-the-counter?
It depends on the product’s cleared indication. Sorbact Superabsorbent (K153674) is cleared for prescription use only. The AQUANOVA submission (K070175) covers both: an over-the-counter indication for minor burns, cuts, abrasions and skin irritation, and a prescription indication for supervised use on ulcers, surgical wounds, burns and bleeding-prone wounds.
What is a dry wound dressing?
The phrase is used loosely. It is not a regulatory category and is not the same as an absorbent dressing, which is defined by how much fluid it takes up.
Sources
- FDA 510(k) summary K153674, Sorbact Foam Gentle Border and Sorbact Superabsorbent, Abigo Medical AB, decision 1 July 2016: accessdata.fda.gov (checked 1 November 2026).
- FDA 510(k) summary K070175, MedTrade Products AQUANOVA Super-Absorbent Dressing, decision 25 July 2007: accessdata.fda.gov (checked 1 November 2026).
- openFDA device 510(k) and classification records for K153674, K070175, product codes FRO and QSY: open.fda.gov (queried 1 November 2026).
- Greenhow H, McSkeane A, Todhunter J. Use of a superabsorbent dressing in wounds with moderate-to-high exudate volume. Journal of Community Nursing, December 2024, pp. 38-43 (abstract checked 1 November 2026): jcn.co.uk.
For the broader category, see what a wound dressing is.
